Marissa Alejandria

About Marissa Alejandria

Marissa Alejandria, With an exceptional h-index of 22 and a recent h-index of 15 (since 2020), a distinguished researcher at University of the Philippines Los Baños, specializes in the field of Infectious Diseases, Clinical Epidemiology, Tropical Medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single Center, Double-blind, Placebo Controlled, Phase 3 Trial

Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with COVID-19: The Co-CLARITY Trial

Burden of Symptoms and Symptom Experience of Filipino Patients with Myeloproliferative Neoplasm: A Qualitative Phenomenological Approach

Reinfection rates, change in antibody titers and adverse events after COVID-19 vaccination among patients previously infected with COVID-19 in Metro Manila, Philippines: a …

Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients in a Tertiary Referral Hospital: A Randomized Controlled Trial

Durability and extent of protection of SARS-CoV-2 antibodies among patients with COVID-19 in Metro Manila, Philippines

Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary …

Predictors of mortality among inpatients with COVID-19 infection in a tertiary referral center in the Philippines

Marissa Alejandria Information

University

Position

___

Citations(all)

5029

Citations(since 2020)

3544

Cited By

2276

hIndex(all)

22

hIndex(since 2020)

15

i10Index(all)

33

i10Index(since 2020)

20

Email

University Profile Page

Google Scholar

Marissa Alejandria Skills & Research Interests

Infectious Diseases

Clinical Epidemiology

Tropical Medicine

Top articles of Marissa Alejandria

Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single Center, Double-blind, Placebo Controlled, Phase 3 Trial

Acta Medica Philippina

2023/5/30

Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with COVID-19: The Co-CLARITY Trial

Acta Medica Philippina

2024/2/15

Burden of Symptoms and Symptom Experience of Filipino Patients with Myeloproliferative Neoplasm: A Qualitative Phenomenological Approach

Acta Medica Philippina

2023/11/16

Reinfection rates, change in antibody titers and adverse events after COVID-19 vaccination among patients previously infected with COVID-19 in Metro Manila, Philippines: a …

BMC Infectious Diseases

2023/11/1

Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients in a Tertiary Referral Hospital: A Randomized Controlled Trial

Acta Medica Philippina

2023/7/31

Durability and extent of protection of SARS-CoV-2 antibodies among patients with COVID-19 in Metro Manila, Philippines

Frontiers in Immunology

2023/6/28

Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary …

Frontiers in Immunology

2023/3/1

Predictors of mortality among inpatients with COVID-19 infection in a tertiary referral center in the Philippines

IJID Regions

2022/9/1

Bacterial coinfection and antimicrobial use among patients with COVID-19 infection in a referral center in the Philippines: A retrospective cohort study

IJID regions

2022/9/1

HIV‐1 Subtype Shift in the Philippines is Associated With High Transmitted Drug Resistance, High Viral Loads, and Fast Immunologic Decline

International Journal of Infectious Diseases

2022/9/1

Marissa Alejandria
Marissa Alejandria

H-Index: 12

Clinical characteristics of patients with asymptomatic and symptomatic COVID-19 admitted to a tertiary referral centre in the Philippines

IJID Regions

2022/3/1

Metabolic profile of people living with HIV in a treatment hub in Manila, Philippines: A Pre-and Post-Antiretroviral analysis

2022

Detection and Genome Sequencing of SARS-CoV-2 Variants Belonging to the B. 1.1. 7 Lineage in the Philippines

Microbiology resource announcements

2021/5/6

Eva Maria Cutiongco-De La Paz
Eva Maria Cutiongco-De La Paz

H-Index: 13

Marissa Alejandria
Marissa Alejandria

H-Index: 12

Are vaccines effective and safe for the prevention of COVID-19 infections? A living systematic review

2021/4/28

Characteristics and factors associated with mortality of 200 COVID-19 patients at a Philippine COVID-19 tertiary referral center

Acta Medica Philippina

2021/4/27

Cybele Lara Abad
Cybele Lara Abad

H-Index: 13

Marissa Alejandria
Marissa Alejandria

H-Index: 12

Genome sequencing and detection of Philippine SARS-CoV-2 infections with viruses classified under the B. 1.1. 7 lineage

medRxiv

2021/3/8

Eva Maria Cutiongco-De La Paz
Eva Maria Cutiongco-De La Paz

H-Index: 13

Marissa Alejandria
Marissa Alejandria

H-Index: 12

Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of the Philippines

MedRxiv

2021/3/5

Eva Maria Cutiongco-De La Paz
Eva Maria Cutiongco-De La Paz

H-Index: 13

Marissa Alejandria
Marissa Alejandria

H-Index: 12

The impact of the implementation of a surgical antibiotic use guideline in the practice of antibiotic use in the Department of Surgery, Philippine General Hospital

Acta Medica Philippina

2021/2/24

Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results

New England journal of medicine

2021/2/11

Effects of brief adjunctive metformin therapy in virologically suppressed HIV-infected adults on polyfunctional HIV-specific CD8 T cell responses to PD-L1 blockade

AIDS Research and Human Retroviruses

2021/1/1

See List of Professors in Marissa Alejandria University(University of the Philippines Los Baños)

Co-Authors

academic-engine